| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $146.0M | +4.2% | +13.1% |
| Cost of Revenue | $35.5M | +1.3% | +8.8% |
| Gross Profit | $110.5M | +5.1% | +14.6% |
| R&D Expense | $44.1M | +12.4% | +29.5% |
| SG&A Expense | $28.1M | +6.5% | +8.9% |
| Operating Income | -$14.2M | -98.5% | -149.8% |
| Pre-tax Income | -$14.4M | -173.9% | -521.7% |
| Income Tax | $1.1M | +61.2% | +70.8% |
| Net Income | -$15.5M | -161.1% | -424.9% |
| EPS (Basic) | -$0.20 | -185.7% | -400.0% |
| EPS (Diluted) | -$0.20 | -185.7% | -400.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $146.8M | -23.2% | -54.6% |
| Accounts Receivable | $80.4M | -32.6% | +31.7% |
| Current Assets | $275.7M | -23.3% | -36.3% |
| Total Assets | $709.1M | -10.8% | -12.8% |
| Current Liabilities | $360.5M | +0.5% | +21.3% |
| Total Liabilities | $388.9M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $100.6M | — | — |
| Capital Expenditures | $1.8M | — | — |
| Investing Cash Flow | -$11.3M | — | — |
| Financing Cash Flow | -$254.7M | — | — |
| Free Cash Flow | $98.8M | — | — |
| +21.1% |
| Stockholders' Equity | $320.2M | -21.9% | -35.0% |